{"id":"https://openalex.org/W2084010197","doi":"https://doi.org/10.1002/cncr.24907","title":"Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three\u2010dimensional lung cancer xenograft model","display_name":"Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three\u2010dimensional lung cancer xenograft model","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-08","ids":{"openalex":"https://openalex.org/W2084010197","doi":"https://doi.org/10.1002/cncr.24907","mag":"2084010197","pmid":"https://pubmed.ncbi.nlm.nih.gov/20143443","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2847044"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.24907","doi":"https://doi.org/10.1002/cncr.24907","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.24907","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24907","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2084010197"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24907","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050135424","display_name":"Xiaoyu Xu","orcid":"https://orcid.org/0000-0002-0327-7369","observed_orcids":["https://orcid.org/0000-0002-0327-7369"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiaoyu Xu","raw_affiliation_strings":["Department of Medicinal Chemistry and The Center for Therapeutic Biomaterials, The University of Utah, Salt Lake City, Utah, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry and The Center for Therapeutic Biomaterials, The University of Utah, Salt Lake City, Utah, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021550395","display_name":"Glenn D. Prestwich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Glenn D. Prestwich","raw_affiliation_strings":["Department of Medicinal Chemistry and The Center for Therapeutic Biomaterials, The University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry and The Center for Therapeutic Biomaterials, The University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021550395"],"corresponding_institution_ids":["https://openalex.org/I223532165"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.6318,"has_fulltext":true,"cited_by_count":97,"citation_normalized_percentile":{"value":0.94493458,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"116","issue":"7","first_page":"1739","last_page":"1750"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lysophosphatidic-acid","display_name":"lysophosphatidic acid","score":0.9819999933242798},{"id":"https://openalex.org/keywords/lpa-receptor-antagonists","display_name":"LPA receptor antagonists","score":0.6930000185966492},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.6930000185966492},{"id":"https://openalex.org/keywords/tumor-vascularization","display_name":"tumor vascularization","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cell-migration-and-invasion","display_name":"cell migration and invasion","score":0.8190000057220459},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.9340000152587891},{"id":"https://openalex.org/keywords/matrigel","display_name":"Matrigel","score":0.8550000190734863},{"id":"https://openalex.org/keywords/laminin","display_name":"laminin","score":0.4779999852180481},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.8406773805618286},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.6781181693077087},{"id":"https://openalex.org/C37547375","wikidata":"https://www.wikidata.org/wiki/Q14913997","display_name":"Autotaxin","level":4,"score":0.6425846815109253},{"id":"https://openalex.org/C2776661833","wikidata":"https://www.wikidata.org/wiki/Q2823281","display_name":"Lysophosphatidic acid","level":3,"score":0.5940564274787903},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5577909350395203},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5137072801589966},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4305137097835541},{"id":"https://openalex.org/C2780278673","wikidata":"https://www.wikidata.org/wiki/Q476743","display_name":"Nude mouse","level":3,"score":0.4249511957168579},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40545588731765747},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3524342179298401},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32503581047058105},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2944047451019287},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2846113443374634},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.25721919536590576},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22574284672737122},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17305058240890503},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005109","descriptor_name":"Extracellular Matrix","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007797","descriptor_name":"Laminin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008246","descriptor_name":"Lysophospholipids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011509","descriptor_name":"Proteoglycans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D020136","descriptor_name":"Hydrogel, Polyethylene Glycol Dimethacrylate","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D023822","descriptor_name":"Tissue Engineering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049368","descriptor_name":"Receptors, Lysophosphatidic Acid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D049368","descriptor_name":"Receptors, Lysophosphatidic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/cncr.24907","doi":"https://doi.org/10.1002/cncr.24907","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.24907","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24907","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:20143443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20143443","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Evaluation Study"},{"id":"pmh:oai:europepmc.org:2075707","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2847044","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2847044","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2847044/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cncr.24907","doi":"https://doi.org/10.1002/cncr.24907","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.24907","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24907","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8614519408","display_name":"Phosphoinositide and Inositol Polyphosphate Probes","funder_award_id":"R01NS029632","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2084010197.pdf","grobid_xml":"https://content.openalex.org/works/W2084010197.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W1504662248","https://openalex.org/W1514923669","https://openalex.org/W1569253487","https://openalex.org/W1574639809","https://openalex.org/W1592017635","https://openalex.org/W1611762702","https://openalex.org/W1967840305","https://openalex.org/W1970824735","https://openalex.org/W1976256366","https://openalex.org/W1978455833","https://openalex.org/W1984250533","https://openalex.org/W1985385147","https://openalex.org/W1988839950","https://openalex.org/W1989267023","https://openalex.org/W1992203600","https://openalex.org/W1994329884","https://openalex.org/W1999457029","https://openalex.org/W2010110193","https://openalex.org/W2010397777","https://openalex.org/W2017608924","https://openalex.org/W2019283447","https://openalex.org/W2024384507","https://openalex.org/W2025044654","https://openalex.org/W2026632078","https://openalex.org/W2032334748","https://openalex.org/W2032461554","https://openalex.org/W2034451004","https://openalex.org/W2037139573","https://openalex.org/W2044461758","https://openalex.org/W2046695461","https://openalex.org/W2047709095","https://openalex.org/W2051214344","https://openalex.org/W2052577849","https://openalex.org/W2061752211","https://openalex.org/W2064795528","https://openalex.org/W2070336923","https://openalex.org/W2076131352","https://openalex.org/W2079701415","https://openalex.org/W2083180345","https://openalex.org/W2085612532","https://openalex.org/W2086811477","https://openalex.org/W2088546959","https://openalex.org/W2088721552","https://openalex.org/W2094210837","https://openalex.org/W2099040322","https://openalex.org/W2105758002","https://openalex.org/W2111792754","https://openalex.org/W2117139617","https://openalex.org/W2120191503","https://openalex.org/W2120639213","https://openalex.org/W2123142773","https://openalex.org/W2129074578","https://openalex.org/W2134825064","https://openalex.org/W2141784683","https://openalex.org/W2145539666","https://openalex.org/W2146317714","https://openalex.org/W2147165555","https://openalex.org/W2151817111","https://openalex.org/W2163402367","https://openalex.org/W2163774665","https://openalex.org/W2164160141","https://openalex.org/W2168877086"],"related_works":["https://openalex.org/W2026491130","https://openalex.org/W2143253820","https://openalex.org/W2994899785","https://openalex.org/W1967840305","https://openalex.org/W2002426801","https://openalex.org/W1972281879","https://openalex.org/W2118523397","https://openalex.org/W2612104173","https://openalex.org/W3169670964"],"abstract_inverted_index":{"BACKGROUND:":[0],":":[1,39,137,220],"We":[2],"developed":[3],"an":[4,232],"engineered":[5,110,240],"three-dimensional":[6],"(3D)":[7],"tumor":[8,151,185,198,207],"xenograft":[9],"model":[10,24],"of":[11,30,50,55,61,105,131,134,145,253],"nonsmall":[12],"cell":[13,62,65,141],"lung":[14,223],"cancer":[15],"(NSCLC)":[16],"in":[17,77,79,93,118,148,161,163,167,189,212,231,246],"nude":[18,94,164],"mice,":[19],"and":[20,35,48,64,90,98,123,143,153,192,197,243],"we":[21],"used":[22],"this":[23],"to":[25,248],"evaluate":[26],"a":[27,42,103,249],"dual-activity":[28],"inhibitor":[29,49,252],"lysophosphatidic":[31],"acid":[32],"(LPA)":[33],"biosynthesis":[34],"receptor":[36],"activation.":[37],"METHODS:":[38],"First,":[40,138],"BrP-LPA,":[41],"pan-antagonist":[43],"for":[44,59,156],"4":[45,128],"LPA":[46,255],"receptors":[47],"the":[51,168,213,254],"lyosphospholipase":[52],"D":[53],"activity":[54,251],"autotaxin,":[56],"was":[57,200,209],"examined":[58],"inhibition":[60],"migration":[63,142],"invasion":[66],"by":[67,203,228],"human":[68],"NSCLC":[69,111],"A549":[70,73,116,146,159,195,214,222],"cells.":[71],"Second,":[72,150],"cells":[74,117,147,160],"were":[75,100,113,125],"encapsulated":[76,158,194],"3D":[78,157,229],"3":[80,132],"semisynthetic":[81,106],"extracellular":[82],"matrices":[83],"(ECMs)":[84],"based":[85],"on":[86],"chemically":[87],"modified":[88],"glycosaminoglycans,":[89],"injected":[91],"subcutaneously":[92],"mice.":[95],"Tumor":[96],"volume":[97],"vascularity":[99,245],"determined":[101],"as":[102],"function":[104],"ECMs":[107],"composition.":[108,238],"Third,":[109,184],"xenografts":[112],"formed":[114],"from":[115],"either":[119],"Extracel-HP":[120,176,178,193],"or":[121],"Matrigel,":[122],"mice":[124,165],"treated":[126,216],"with":[127,217,235],"intraperitoneal":[129],"injections":[130],"mg/kg":[133],"BrP-LPA.":[135,218],"RESULTS:":[136],"BrP-LPA":[139,204],"inhibited":[140,202],"invasiveness":[144],"vitro.":[149],"growth":[152,180,199],"microvessel":[154],"formation":[155],"vivo":[162],"increased":[166,187],"following":[169],"order:":[170],"buffer":[171],"only":[172],"<":[173,175,177],"Extracel":[174],"containing":[179],"factorss":[181],"plus":[182],"laminin.":[183],"volumes":[186],"rapidly":[188],"both":[190],"Matrigel":[191],"cells,":[196],"markedly":[201],"treatment.":[205],"Finally,":[206],"vascularization":[208],"dramatically":[210],"reduced":[211],"tumors":[215,224,241],"CONCLUSIONS:":[219],"Engineered":[221],"can":[225],"be":[226],"created":[227],"encapsulation":[230],"ECM":[233],"substitute":[234],"user":[236],"controlled":[237],"The":[239],"regress":[242],"lose":[244],"response":[247],"dual":[250],"signaling":[256],"pathway.":[257],"Cancer":[258,263],"2010.":[259],"(c)":[260],"2010":[261],"American":[262],"Society.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2084010197","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
